# Optimal Application Dose of Superficial Hyperthermia

> **NCT00766233** · PHASE3 · COMPLETED · sponsor: **Universitätsmedizin Mannheim** · enrollment: 17 (actual)

## Conditions studied

- Tumors

## Interventions

- **OTHER:** Hyperthermal treatment

## Key facts

- **NCT ID:** NCT00766233
- **Lead sponsor:** Universitätsmedizin Mannheim
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2016-01
- **Final completion:** 2016-02
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2021-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00766233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00766233, "Optimal Application Dose of Superficial Hyperthermia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00766233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*